Anticoagulation control in atrial fibrillation patients present to outpatient clinic of cardiology versus anticoagulant clinics

Chinese Medical Journal

Volumn 118, Issue 14, 2005, Pages 1206-1209

  Du, Xin ^a   Ma, Chang Sheng ^a   Liu, Xiao Hui ^a   Dong, Jian Zeng ^a   Wang, Jun Nan ^a   Cheng, Xiao Jing ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Anticoagulant clinics; Anticoagulation control; Atrial fibrillation

Indexed keywords

ANTICOAGULANT AGENT; WARFARIN;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; BRAIN HEMORRHAGE; CARDIOLOGY; CONSULTATION; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; DISEASE CONTROL; ECHOCARDIOGRAPHY; FEMALE; HEALTH CARE DELIVERY; HEALTH CARE QUALITY; HEART ATRIUM FIBRILLATION; HUMAN; INTERNATIONAL NORMALIZED RATIO; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; OUTPATIENT DEPARTMENT; RISK FACTOR; STATISTICAL ANALYSIS; THROMBOEMBOLISM; THROMBOSIS; VALVULAR HEART DISEASE;

AGE FACTORS; AGED; ANTICOAGULANTS; ATRIAL FIBRILLATION; FEMALE; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; MIDDLE AGED;

EID: 22944438409     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Wolf PA, Abbott RD, Kannel WB, et al. Atrial fibrillation as an independent risk factor for stroke: The Framingham Study. Stroke 1991;22:983-988.
2. Peterson P, Boysen G, Gotfriedsen J, et al. Placebo-controlled, randomized trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK Study. Lancet 1989;1:175-179.
3. The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. The effect of low-dose warfarin on the risk of stroke in patients with non-rheumatic atrial fibrillation. N Engl J Med 1990;323:1505-1511.
4. Stroke Prevention in Atrial Fibrillation Investigators. Stroke prevention in atrial fibrillation study: Final results. Circulation 1991;84:527-539.
5. Connolly SJ, Laupacis A, Gent M, et al. Canadian atrial fibrillation anticoagulation (CAFA) study. J Am Coll Cardiol 1991;18:349-355.
6. Ezekowitz MD, Bridgers SL, James KE, et al. Warfarin in the prevention of stroke associated with nonreumatic atrial fibrillation. N Engl J Med 1992;327: 1406-1412.
7. Stroke Prevention in Atrial Fibrillation Investigators. Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II Study. Lancet 1994;343:687-691.
8. European Atrial Fibrillation Trial Study Group. Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack of minor stroke. Lancet 1993;32:1255-1262.
9. Ansell JE, Hughes R. Evolving models of warfarin management: anticoagulation clinics, patient self-monitoring, and patient self-management. Am Heart J 1996;132:1095-1100.
10. Bungard TJ, Ghali WA, Teo KK, et al. Why do patients with atrial fibrillation not receive warfarin? Arch Intern Med 2000;160:41-46.
11. Hambleton J. Home monitoring of anticoagulation. J Thromb Thrombolysis 2003;16:39-42.
12. Voller H, Glatz J, Taborski U, et al. Self-management of oral anticoagulation in nonvalvular atrial fibrillation (SMAAF study). Z Kardiol 2005;94:182-186.
13. Kortke H, Korfer R. International normalized ratio self-management after mechanical heart valve replacement: is an early start advantageous? Ann Thorac Surg 2001 72:44-48.
14. McCormick D, Gurwitz JH, Goldberg J, et al. Long-term anticoagulation therapy for atrial fibrillation in elderly patients: efficacy, risk, and current patterns of use. J Thromb Thrombolysis 1999;7:157-163.
15. Jones M, McEwan P, Morgan C LI, et al. Evaluation of the pattern of treatment, level of anticoagulation control, and outcome of treatment with warfarin in patients with nonvalvar atriall fibrillation: a record linkage study in a large British population. Heart 2005;91:472-477.